Francoise Adan, MD
This year’s keynote speaker Francoise Adan, MD will present the program, “Stress Management & Resilience: How to be Your Best Self While Living with Chronic Disease.” Dr. Adan is the Endowed Connor Chair of Integrative Medicine at University Hospitals in Cleveland, and the recipient of the Christopher M. & Sara H. Connor Master Clinician in Integrative Health. She is also an assistant Professor at Case Western Reserve University Medical School and a member of the Steering Committee for the Medical School Women’s Faculty. One area of expertise for Dr. Adan is anxiety disorders. In more than 25 years of practicing medicine, Dr. Adan has always practiced mind/body medicine, encouraging clients and patients to understand the connection between the mind, the body and the spirit. In her early years of medical practice she was quick to recognize the limitations of traditional medicine and to embrace the benefits of practicing with a more integrative approach, becoming a champion of holistic wellbeing. Trained in psychiatry and board certified in Holistic and Integrative medicine, Dr. Adan specializes in three areas: stress management, work/life balance and the mind/body/spirit connection. Dr. Adan writes that she has witnessed and been impacted by the resilience of more than 4,000 patients and clients during her career, never ceasing to be amazed at the courage individuals possess to transform their own lives.
Donald M. Arnold, MDCM, MSc, FRCP(C)
Dr. Arnold is an Assistant Professor in the Department of Medicine at McMaster University in Hamilton, Canada and Program Director for the McMaster Transfusion Medicine Residency Program. Dr. Arnold obtained his MD from McGill University and completed training in Internal Medicine at the Jewish General Hospital in Montreal. He then completed Hematology training at McMaster in 2003 and a Fellowship in Transfusion Medicine supported by the Canadian Blood Services and the Canadian Institutes for Health Research (CIHR). He holds a Master's degree in Health Research Methodology from McMaster and is the recipient of a CIHR New Investigator Award. Dr. Arnold is a translational researcher with a focus on immune thrombocytopenia (ITP). He is the lead investigator on several clinical trials in ITP and has developed a program of research that spans clinical studies designed to better understand patient preferences with respect to ITP treatments to basic research on the mechanisms of ITP.
Terry Gernsheimer, MD
Dr. Terry Gernsheimer is Professor of Medicine at the University of Washington School of Medicine, Medical Director of the Platelet Antibody Laboratory at the Puget Sound Blood Center, and Director of Transfusion Services for the University of Washington Medical Center and the Seattle Cancer Care Alliance. Dr. Gernsheimer's research focuses on the pathophysiology and treatment of immune platelet disorders and pathologic immune responses associated with transfusion. She has clinical research interest in transfusion management of the hematopoietic stem cell transplant patient and surgical bleeding in patients undergoing solid organ transplant and cardiovascular procedures. She has made significant contributions toward understanding the pathophysiology and management of auto-immune thrombocytopenic purpura (ITP). Dr. Gernsheimer serves on the PDSA Board of Medical Advisors.
Craig Kessler, MD
Dr. Craig Kessler is professor of Medicine and Pathology and Section Chief of Hematology. He is also Director of the Coagulation Laboratory at Georgetown. A graduate of Tulane School of Medicine, Dr. Kessler received his specialty training in hematology and oncology at The Johns Hopkins Hospital. An international expert in the area of disorders of coagulation, Dr. Kessler has a particular interest in hemophilia. He also has expertise in the treatment of hematologic malignancies. Dr. Kessler also serves on the PDSA Board of Medical Advisors.
David J. Kuter, MD, DPhil
Dr. David Kuter is Chief of Hematology, Massachusetts General Hospital, Boston, Massachusetts. He earned a research doctorate (DPhil) at Magdalen College of Oxford University and a medical degree at Harvard Medical School. Dr. Kuter is Professor of Medicine at Harvard Medical School and Chief of Hematology at the Massachusetts General Hospital. In addition, Dr. Kuter sits on numerous national and international ITP committees and is board certified in Internal Medicine, Hematology, and Medical Oncology. He has dedicated years of effort to researching coagulopathies, anticoagulation, and platelet disorders. In recent years, Dr. Kuter has conducted groundbreaking research into the development of effective thrombopoietic agents. Dr. Kuter also serves on the PDSA Board of Medical Advisors.
Michele P. Lambert, MD, MTR
Dr. Lambert is an Assistant Professor of Clinical Pediatrics at the Children’s Hospital of Philadelphia and Medical Director of the Special Coagulation Laboratory at CHOP. She graduated from UMDNJ-New Jersey Medical School (now Rutgers) and completed her pediatric residency at St. Christopher’s Hospital for Children followed by a year as Chief Resident. She then moved the Children’s Hospital of Philadelphia were she completed her fellowship in pediatric hematology/oncology. She received her Masters in Translational Medicine in 2001. Her research efforts have focused on understanding the control of platelet production by megakaryocytes (the cells that make platelets) and the ways in which genetics influence platelet function and number in various clinical scenarios including ITP and inherited platelet disorders. Dr. Lambert serves on the PDSA Board of Medical Advisors.
Howard A. Liebman, MD
Dr. Howard Liebman is Professor of Medicine and Pathology at the University of Southern California (USC) Keck School of Medicine, Los Angeles, CA. He serves as Medical Director of the Special Hemostasis Laboratory at the USC NorrisComprehensiveCancerCenter and is Director of the fellowship program in hematology. Dr. Liebman received his medical degree from USC and completed his postgraduate training including a residency in internal medicine and fellowships in medical oncology and hematology at Los AngelesCounty - University of Southern California Medical Center. Dr. Liebman completed a research fellowship at TuftsUniversity - New EnglandMedicalCenter, Boston, MA, and held faculty positions at TuftsUniversity and BostonUniversity, before returning to USC. Dr. Liebman's research interests include clinical management and characterization of haemostatic and thrombotic disorders, management of autoimmune blood disorders, and clinical therapy of HIV and AIDS. He has authored or co-authored 85 peer-reviewed publications and 26 reviews and chapters. Dr. Liebman also serves on the PDSA Board of Medical Advisors.
Keith McCrae, MD
Dr. Keith McCrae is a physician-scientist and Director of Hematology at Cleveland Clinic. He received his MD degree and training in internal medicine at Duke University, and subsequently trained in Hematology at the University of Pennsylvania. He was a faculty member at the University of Pennsylvania, Temple and Case Western before joining the Cleveland Clinic in 2010. In addition to patient care, he maintains active clinical and laboratory-based research programs. His clinical interests include ITP, the antiphospholipid antibody syndrome, and several other hematologic disorders. His laboratory focuses on platelets, immune-mediated endothelial cell activation, and mechanisms of thrombosis in patients with cancer. He is active in many programs of the American Society of Hematology, and is Deputy Editor of the annual ASH Education book. He is also a frequent grant reviewer at the National Institutes of Health.
John W. Semple, PhD
Dr. John Semple received his PhD in Immunology from Queen's University in 1986 and trained as a Post-Doctoral Fellow in the Banting and Best Department of Medical Research of the C.H. Best Institute, University of Toronto from 1986-1990. He joined St. Michael’s Hospital in 1990 and was a Senior Staff Scientist and Head of the Toronto Platelet Immunobiology Group at the Keenan Research Centre for Biomedical Sciences. He was also a Professor in the Departments of Pharmacology, Medicine and Laboratory Medicine and Pathobiology at the University of Toronto and an Adjunct Scientist with Canadian Blood Services. He joined Lund University in 2016 as a Professor of Transfusion Medicine of St. Michael’s Hospital. Dr. Semple has published over 120 papers on platelet immunology. His research activities include several areas including anti-platelet T cell responses in patients with acute and chronic ITP, the analysis of how platelet antigens are recognized by the immune system, and how platelets may act as immune-like cells that are responsible for initiating and perpetuating their own autoimmune demise. Dr. Semple also serves on the PDSA Board of Medical Advisors.
Michael Tarantino, MD
Dr. Michael Tarantino is a Professor of Pediatrics and Medicine at the University of Illinois College of Medicine-Peoria and Medical Director of the Bleeding & Clotting Disorders Institute. He received a doctoral degree in medicine from the University of Wisconsin School of Medicine in 1987. He completed an internship and residency at the University of Arizona Health Sciences Center and a Fellowship in Pediatric Hematology/Oncology at the University of Wisconsin School of Medicine. Dr. Tarantino first became interested in ITP during his residency in 1988. Since that time he has designed and/or participated in numerous clinical investigations related to ITP and other platelet disorders. He has authored numerous publications relevant to the diagnosis and management of ITP, especially as it occurs in children. He is also active in hemophilia and other bleeding disorders research, and founded The Bleeding and Clotting Disorders Institute in 2010. Dr. Tarantino serves on the PDSA Board of Medical Advisors.